Table 3.

Fatality and utility used in base-case analysis.

Model parameter	Base-case value (raw)	Base-case value (%/year)	Distribution
Fatality
Heart failure	4/1,223	0.32%	Beta
Myocardial infarction	0/61	0.00%	Beta
Ischemic stroke	2/92	2.17%	Beta
Intracranial hemorrhage	1/8	12.50%	Beta
GI bleeding	1/54	1.85%	Beta
Utility
Warfarin (20)	0.987	0.987	Gamma
Rivaroxaban (20)	0.994	0.994	Gamma
Dabigatran (21)	0.970	0.970	Gamma
Apixaban (21)	0.998	0.998	Gamma
Edoxaban (21)	0.998	0.998	Gamma
Heart failure (22)	0.69	0.69	Beta
Myocardial infarction (23)	0.84	0.84	Beta
Ischemic stroke (24)	0.41	0.41	Beta
Intracranial hemorrhage (24)	0.56	0.56	Beta
GI bleeding (25)	0.70	0.70	Beta

GI, gastrointestinal.